alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Clinical trials

Clinical trials

Every Alzheimer's trial in our copy of the ClinicalTrials.gov registry — completed, running and abandoned. Filter it, then follow the link to the official record.

If you are thinking about joining a trial

A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.

Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.

Clear filters Download all 7,816 as CSV

"Open to new participants" means the registry status is RECRUITING or NOT_YET_RECRUITING — 1,523 of the 7,816 records. That is what the sponsor last told the registry, which can be months out of date.
Location is by country. This pull of the registry records the countries a study runs in, not its individual sites, so we cannot filter by US state or city — and we are not going to guess one. To find the nearest site, open a trial's record below: the official page lists every location with its contact details.

Showing 6,626–6,650 of 7,816 matching trials · page 266 of 313, 25 per page.

Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.

Registered Alzheimer's clinical trials. Every ID links to its official ClinicalTrials.gov record.
Trial Phase Status Enrolled Sponsor Last updated
Normalization of dyrk1A and APP Function as an Approach to Improve Cognitive Performance and Decelerate AD Progression in DS Subjects: Epigallocatechin Gallate as Therapeutic Tool
NCT01699711
Epigallocatechin-3-gallate (EGCG)
Runs in: Spain · 1 site 		PHASE2
other		 COMPLETED 87 Parc de Salut Mar
OTHER		 2016-02-11
Neurocognitive Effects of Bilateral STN Versus GPi DBS in Parkinson's Disease Patients With MCI
NCT01870518
Bilateral GPi DBS; Bilateral STN DBS
Runs in: United States · 1 site 		NA
other		 TERMINATED 13 St. Joseph's Hospital and Medical Center, Phoenix
OTHER		 2016-02-10
Transcranial Magnetic Stimulation for Apathy in Mild Cognitive Impairment:Pilot Study
NCT02190019
Neurostar repetitive transcranial magnetic stimulator
Runs in: United States · 1 site 		PHASE4
other		 UNKNOWN 14 Central Arkansas Veterans Healthcare System
OTHER_GOV		 2016-02-10
IMPACT: A Study to Explore the Efficacy and Safety of Paliperidone ER in Patients With Acute Agitation
NCT01050478
Paliperidone ER; Benzodiazepine
Runs in: Belgium · 14 sites 		PHASE4
other		 COMPLETED 56 Janssen Cilag N.V./S.A.
INDUSTRY		 2016-02-09
The Role of Mid-Life Adiposity in Functional Brain Connectivity
NCT01777789
Runs in: United States · 1 site 		NA
other		 TERMINATED 60 Medical College of Wisconsin
OTHER		 2016-02-09
FluoroAv45 Imaging Research-in Alzheimer's Disease
NCT01325259
neuropsychologic assessment; [18F]AV-45 PET; 18-FDG PET; MRI
Runs in: France · 4 sites 		PHASE2
other		 COMPLETED 54 University Hospital, Tours
OTHER		 2016-02-08
Using Hypnotherapy For Dementia & Alzheimer's
NCT01435551
Hypnotherapy 		NA
other		 NO_LONGER_AVAILABLE — Families To The Rescue
OTHER		 2016-02-04
Study Evaluating Safety, Tolerability, and PK of Multiple Ascending Doses of GC021109 in Subjects With Mild to Moderate Alzheimer's Disease
NCT02386306
GC021109; Placebo
Runs in: United States · 5 sites 		PHASE1
other		 COMPLETED 39 GliaCure, Inc.
INDUSTRY		 2016-02-03
Computerized Cognitive Training Program for Older Persons With Mild Dementia
NCT02671630
A community-based computerized cognitive training program 		NA
other		 COMPLETED 30 Far Eastern Memorial Hospital
OTHER		 2016-02-02
Serotonin Transporter Density in Late-life Depression With and Without Dementia
NCT01548937
I-123 ADAM 		PHASE2
other		 COMPLETED 39 Chang Gung Memorial Hospital
OTHER		 2016-01-28
Measuring the Impact of Cognitive and Psychosocial Interventions in Persons With Mild Cognitive Impairment
NCT01448148
Cognitive intervention; Psychosocial intervention
Runs in: Canada · 2 sites 		NA
other		 COMPLETED 145 Centre de Recherche de l'Institut Universitaire de Geriatrie de Montreal
OTHER		 2016-01-27
The Trinity, Ulster and Department of Agriculture Cohort Study
NCT02664584
Runs in: Ireland; United Kingdom · 3 sites 		NA
other		 UNKNOWN 5,186 University of Ulster
OTHER		 2016-01-27
The Effects of Midazolam on the Quality of Postoperative Recovery
NCT01993459
Midazolam; NaCl (sodium chloride) 0,9%
Runs in: Netherlands · 1 site 		PHASE4
other		 COMPLETED 192 Erasmus Medical Center
OTHER		 2016-01-26
" The Eyes Have it " : Ocular Saccade Abnormalities in Prodromal Alzheimer's Disease
NCT01630525
Neuropsychological assessment; ophthalmologic checkup; Automated no...
Runs in: France · 3 sites 		NA
other		 COMPLETED 83 University Hospital, Bordeaux
OTHER		 2016-01-25
Probiotics in the Treatment of Iron Deficiency in Children With Restless Leg Syndrome
NCT01617044
Probiotics; Placebo
Runs in: United States · 1 site 		PHASE2
other		 COMPLETED 61 Children's Hospitals and Clinics of Minnesota
OTHER		 2016-01-20
Detection of Disease-Related Changes in Pre-Symptomatic Alzheimer's Disease
NCT01841905
Observational Study
Runs in: United States · 1 site 		NA
other		 UNKNOWN 60 Rhode Island Hospital
OTHER		 2016-01-20
Group Therapy for Caregivers of Alzheimer's Disease Patients in Spanish Elderly Persons Centres
NCT02418806
Psychotherapy groups; Self-help groups
Runs in: Spain · 11 sites 		NA
other		 COMPLETED 231 Barcelonabeta Brain Research Center, Pasqual Maragall Foundation
OTHER		 2016-01-20
Pioglitazone Or Exercise to Treat Mild Cognitive Impairment (MCI)
NCT00736996
Pioglitazone; Placebo; Endurance Exercise Training
Runs in: United States · 1 site 		PHASE2
other		 COMPLETED 78 University of Colorado, Denver
OTHER		 2016-01-15
Cognitive Assessment of Elderly Primary Care Patients
NCT01492335
Cognitive Report; Treatment As Usual
Runs in: United States · 1 site 		NA
other		 COMPLETED 524 University of Pittsburgh
OTHER		 2016-01-14
A Composite MR Neuroimaging Marker for Alzheimer's Disease
NCT01615666
Runs in: United States · 1 site 		NA
other		 WITHDRAWN 0 Medical College of Wisconsin
OTHER		 2016-01-14
Enhanced External Counterpulsation and Its Effects on Vascular Hemodynamics in Cognitively Impaired Patients
NCT01659398
External Counterpulsation (EECP)
Runs in: United States · 1 site 		EARLY_PHASE1
other		 COMPLETED 8 Patrick Moriarty, MD, FACP, FACC
OTHER		 2016-01-13
Neurogenetic Pharmaceuticals (NGP) 555 in Healthy Young Volunteers (Single-ascending Dose)
NCT02534480
NGP 555
Runs in: United States · 1 site 		PHASE1
other		 COMPLETED 40 NeuroGenetic Pharmaceuticals Inc
INDUSTRY		 2016-01-13
Development of Therapeutic Intervention for Sleep in Alzheimer/Caregiver Dyads
NCT02506374
Runs in: United States · 1 site 		NA
other		 WITHDRAWN 0 Yale University
OTHER		 2016-01-12
Evaluation of Safety & Tolerability of Multiple Dose Regimens of CHF 5074
NCT01303744
CHF 5074 1x; CHF 5074 2x; CHF 5074 3x; Placebo
Runs in: Italy; United States · 9 sites 		PHASE2
other		 COMPLETED 96 CERESPIR
INDUSTRY		 2016-01-11
Study Evaluating The Efficacy And Safety Of Bapineuzumab In Alzheimer Disease Patients
NCT00667810
bapineuzumab; bapineuzumab; placebo
Runs in: Argentina; Australia; Belgium; Canada; Chile; Croatia; Fi... · 346 sites 		PHASE3
anti-amyloid-antibody		 TERMINATED 901 Pfizer
INDUSTRY		 2016-01-08

This table is wider than a phone screen — swipe it sideways to see the rest.

Where these trials come from

Registry
ClinicalTrials.gov, pulled through their public API (v2)
Trials in the file
7,816
Source file
trials.csv (3.8 MB, 7816 rows)
Basis
Measured These are registry records as submitted by each study's sponsor.

What could make this misleading

Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.

Always check the official record before acting on anything here. This is a summary, not medical advice.

Related evidence Treatments → What the drugs that finished their trials actually achieved.

From the research library

The highest-scoring studies we hold on this subject, each summarised in plain English. Scores are alzhub's usefulness score, not a verdict on the science.

Clinical trials

All 162 studies on Clinical trials →